Literature DB >> 9692467

Surgical treatment of hepatic and pulmonary metastases from colorectal cancers.

J F Regnard1, D Grunenwald, L Spaggiari, P Girard, D Elias, M Ducreux, P Baldeyrou, P Levasseur.   

Abstract

BACKGROUND: Selected patients with double hepatic and pulmonary metastases from colorectal cancer may benefit from operation.
METHODS: From 1970 to 1995, 239 patients underwent operation for resection of pulmonary metastases from colorectal cancer at two French surgical centers. Among these patients, 43 (18%) had previously undergone complete resection of hepatic metastases and constitute the subject of this retrospective study.
RESULTS: The median interval time between hepatic and pulmonary resections was 18 months. Two pneumonectomies, 5 lobectomies, 3 segmentectomies, 6 wedge resections, and 27 metastasectomies were performed. No postoperative mortality was observed. Two patients had major postoperative complications. Seven patients (16%) underwent subsequent pulmonary resection for recurrences. Twenty-one patients were still alive, 14 free of disease. The median survival from pulmonary resection was 19 months and the 5-year probability of survival was 11%. Prethoracotomy carcinoembryonic antigen blood levels and the number of pulmonary resection were found to be significant prognostic factors; the interval time between hepatic and pulmonary resection (> 36 months) was borderline significant (p = 0.06).
CONCLUSIONS: Selected patients with combined hepatic and pulmonary metastases from colorectal cancer should be considered for surgical resection. Patients with normal prethoracotomy carcinoembryonic antigen levels and late metachronous pulmonary metastasis, appear to be the best surgical candidates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692467     DOI: 10.1016/s0003-4975(98)00269-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  48 in total

1.  Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases.

Authors:  Michel Gonzalez; John Henri Robert; Nermin Halkic; Gilles Mentha; Arnaud Roth; Thomas Perneger; Hans Beat Ris; Pascal Gervaz
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

2.  Optimal use of current chemotherapy in multimodality therapy for advanced colorectal cancer.

Authors:  Yasuhiro Inoue; Junichiro Hiro; Yuji Toiyama; Koji Tanaka; Yasuhiko Mohri; Masato Kusunoki
Journal:  Oncol Lett       Date:  2011-12-01       Impact factor: 2.967

3.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.

Authors:  Toshiaki Watanabe; Michio Itabashi; Yasuhiro Shimada; Shinji Tanaka; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Ichinosuke Hyodo; Masahiro Igarashi; Hideyuki Ishida; Megumi Ishiguro; Yukihide Kanemitsu; Norihiro Kokudo; Kei Muro; Atsushi Ochiai; Masahiko Oguchi; Yasuo Ohkura; Yutaka Saito; Yoshiharu Sakai; Hideki Ueno; Takayuki Yoshino; Takahiro Fujimori; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Keiichi Takahashi; Hiroya Takiuchi; Osamu Tsuruta; Toshiharu Yamaguchi; Masahiro Yoshida; Naohiko Yamaguchi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2011-10-15       Impact factor: 3.402

Review 4.  Current directions in chemotherapy for colorectal cancer.

Authors:  Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

Review 5.  Evolving management of colorectal cancer.

Authors:  Jochem van der Voort van Zijp; Harald J Hoekstra; Marc D Basson
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

6.  Analysis of treatment that includes both hepatic and pulmonary resections for colorectal metastases.

Authors:  Takashi Matsui; Tosuke Kitamura; Heita Ozawa; Haruhisa Matsuguma; Kenjiro Kotake
Journal:  Surg Today       Date:  2013-10-31       Impact factor: 2.549

7.  Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial.

Authors:  Vassiliki L Tsikitis; Kishore Malireddy; Erin A Green; Brent Christensen; Richard Whelan; Jace Hyder; Peter Marcello; Sergio Larach; David Lauter; Daniel J Sargent; Heidi Nelson
Journal:  J Clin Oncol       Date:  2009-06-29       Impact factor: 44.544

8.  Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs.

Authors:  Norifumi Hattori; Yukihide Kanemitsu; Koji Komori; Yasuhiro Shimizu; Tsuyoshi Sano; Yoshiki Senda; Tetsuya Mitsudomi; Takayuki Fukui
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

9.  Prognostic Significance of the Immunological Indices in Patients Who Underwent Complete Resection of Pulmonary Metastases of Colorectal Cancer.

Authors:  Yuki Okazaki; Masatsune Shibutani; E N Wang; Hisashi Nagahara; Tatsunari Fukuoka; Yasuhito Iseki; Shinichiro Kashiwagi; Hiroaki Tanaka; Kiyoshi Maeda; Kosei Hirakawa; Masaichi Ohira
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

10.  Aggressive surgical resection for concomitant liver and lung metastasis in colorectal cancer.

Authors:  Sung Hwan Lee; Sung Hyun Kim; Jin Hong Lim; Sung Hoon Kim; Jin Gu Lee; Dae Joon Kim; Gi Hong Choi; Jin Sub Choi; Kyung Sik Kim
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2016-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.